Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 411-380-6 | CAS number: 147315-50-2 CG 30-1577
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
The substance is expected to be stable under the conditions of stomach and duodenum and to pass the intestines unchanged and to be excreted directly via faeces. The absence of any liver effects in the course of the 28 day oral toxicity study supports the assumption that most of the test substance is not bioavailable. A bioaccumulation of the test item is not expected.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Functional groups relevant for hydrolysis
The substance contains an ether which is generally stable with regard to pH-dependent hydrolysis at pH values present in the gastrointestinal tract.
Functional groups relevant for elimination
The route of excretion is assumed to be via the biles using the glucuronic acid-conjugate pathway. Glucuronic acid conjugates are most likely formed with the phenolic -OH group. It is considered rather unlikely, that water-soluble metabolites would be formed by oxidation along the sidechain. Glucuronidated metabolites are generally known to be rapidly excreted.
Indication of uptake
In the intestines, due to its very low solubility in water and the large molecular weight only a small amount of the article is expected to be absorbed. Almost the entire ingested test item is expected to pass the intestines unchanged and to be excreted directly via faeces. With respect to the very small part of the substance resorbed, most is expected to become directly glucuronidated in the liver and excreted via the bile. This is likely as the substance has a free phenolic hydroxyl group.
Evaluation of the bioaccumulation potential
A bioaccumulation of the test substance is considered unlikely, due to the fact that in the course of a 28d study perfomed with a structural analogue at high doses, slight reversible liver induction was shown, which is indirect evidence that metabolism and excretion takes place.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
